BIO.News Newsletter

A new study, led by BIO’s Dr. Leah Buchman, shows the link between public trust in regulators and support for gene drive in agriculture. Plus, April is Primary Immunodeficiency Month—the Immune Deficiency Foundation shares five things you should know. (609 words, 3 minutes, 2 seconds)

Happy Tax Day. We take a deep dive into what biotech is doing about bird flu, and why biotech should be part of the conversation this week during the U.N. General Assembly's Sustainability Week. (576 words, 2 minutes, 52 seconds)

Yesterday, the House Ways & Means Committee revived discussion of legislation to restore immediate R&D expensing—we recap. Plus, Sen. Bernie Sanders’ idea for a “long COVID moonshot” is admirable—but price controls could thwart the companies already researching this disease (and others). (544 words, 2 minutes, 43 seconds)

We recap what BIO Board member company Ginkgo Bioworks said about AI and IP on Capitol Hill yesterday—plus, BIO comments on a proposed update to the Medicaid Drug Rebate Program (MDRP) and BIO CEO John F. Crowley wins a leadership award from Life Sciences PA. (881 words, 4 minutes, 24 seconds)

PCOS is underrecognized and underresearched—yet it’s a common cause of infertility. We look at what should be done—plus, a “lab on wheels” that brings biotech to rural students in Maine. (585 words, 2 minutes, 55 seconds)

“Biotech is climate tech” is the message of today's new episode of the I am BIO Podcast—plus, a BIO member’s promising drug targeting an ultra-rare disease with unmet need will get FDA review. (517 words, 2 minutes, 35 seconds)

It’s all about platform technology today—from a platform developing animal-free meat and dairy and innovative de-icing technology, to how platform technology can drive rare disease R&D. (558 words, 2 minutes, 47 seconds)

Today, we recap the World Vaccine Congress in Washington, D.C., and look at a recent report highlighting the economic and environmental benefits of biobased products. Enjoy the weekend. (532 words, 2 minutes, 39 seconds)

Breaking this morning: BIO President and CEO John F. Crowley writes in STAT News why the U.S. must maintain its leadership in biotechnology (and how). Plus, dengue is spreading—and warmer weather is to blame. (581 words, 2 minutes, 54 seconds)

A new report highlights the economic impact of Texas’s life sciences sector, and the USDA recently cleared a genetically modified hemp. (500 words, 2 minutes, 30 seconds)